Skip to main content

ORBIMED ADVISORS LLC

Position in DYN — Dyne Therapeutics, Inc.

CIK 1055951 New York, NY

Position in DYN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$71,864,541
+$18,963,305 QoQ
Shares Held
3,235,684
+10.9% QoQ
Ownership
1.73%
of shares outstanding
% of Portfolio
1.42%
of 13F equity value
Holder Rank
#15
of 245 holders
Holding Since
Sep 2020
15 quarters on record
Voting authority Sole 30% Shared 0% None 70%

Common Shares in DYN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ORBIMED ADVISORS LLC holds $3,639,640,835 across 90 Biotechnology names. DYN ranks #13 (2.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in DYN

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $71,864,541 3,235,684
2026-03-31 $52,901,236 2,917,884
2025-12-31 $43,074,719 2,202,184
2025-09-30 $29,274,427 2,314,184
2025-06-30 $9,818,928 1,031,400
2025-03-31 $10,612,831 1,014,611
2024-12-31 $28,910,004 1,227,080
2024-09-30 $25,445,728 708,400
2024-06-30 $24,999,436 708,400
2024-03-31 $20,111,476 708,400
2022-09-30 $2,799,080 220,400
2021-06-30 $7,364,000 350,000
2021-03-31 $5,435,500 350,000
2020-12-31 $7,350,000 350,000
2020-09-30 $7,066,500 350,000